HR has been the subject of several recent research reports. BTIG Research reissued a "buy" rating and issued a $20.00 price objective on shares of Healthcare Realty Trust in a report on Wednesday, September 10th. Wall Street Zen cut shares of Healthcare Realty Trust from a "hold" rating to a "sell" rating in a research report on Saturday, May 31st. Raymond James Financial cut Healthcare Realty Trust from a "market perform" rating to an "underperform" rating in a research note on Monday, September 15th. Scotiabank upgraded shares of Healthcare Realty Trust from a "sector perform" rating to a "sector outperform" rating and raised their price objective for the company from $18.00 to $20.00 in a research report on Friday, September 5th. Finally, Wells Fargo & Company raised their target price on shares of Healthcare Realty Trust from $15.00 to $16.00 and gave the stock an "underweight" rating in a report on Wednesday, August 27th.